Department of Pharmaceutical Life Sciences, Faculty of Pharmaceutical Sciences, Hokuriku Universitygrid.412171.0, Ishikawa, Japan.
Research Center for Pharmaceutical Education, Faculty of Pharmaceutical Sciences, Hokuriku Universitygrid.412171.0, Ishikawa, Japan.
Microbiol Spectr. 2022 Feb 23;10(1):e0134221. doi: 10.1128/spectrum.01342-21. Epub 2022 Feb 9.
Human phospholipid scramblase 1 (PLSCR1) is strongly expressed in response to interferon (IFN) treatment and viral infection, and it has been suggested to play an important role in IFN-dependent antiviral responses. In this study, we showed that the levels of human cytomegalovirus (HCMV) plaque formation in OUMS-36T-3 (36T-3) cells with high basal expression of PLSCR1 were significantly lower than those in human embryonic lung (HEL) cells with low basal expression of PLSCR1. In addition, the levels of HCMV plaque formation and replication in PLSCR1-knockout (KO) 36T-3 cells were significantly higher than those in parental 36T-3 cells and were comparable to those in HEL cells. Furthermore, compared to that in PLSCR1-KO cells, the expression of HCMV major immediate early (MIE) proteins was repressed and/or delayed in parental 36T-3 cells after HCMV infection. We also showed that PLSCR1 expression decreased the levels of the cAMP-responsive element (CRE)-binding protein (CREB)•HCMV immediate early protein 2 (IE2) and CREB-binding protein (CBP)•IE2 complexes, which have been suggested to play important roles in the IE2-mediated transactivation of the viral early promoter through interactions with CREB, CBP, and IE2. Interestingly, PLSCR1 expression repressed CRE- and HCMV MIE promoter-regulated reporter gene activities. These observations reveal, for the first time, that PLSCR1 negatively regulates HCMV replication by repressing the transcription from viral MIE and early promoters, and that PLSCR1 expression may contribute to the IFN-mediated suppression of HCMV infection. Because several IFN-stimulated genes (ISGs) have been reported to suppress HCMV replication, HCMV replication is thought to be regulated by an IFN-mediated host defense mechanism, but the mechanism remains unclear. PLSCR1 expression is induced in response to viral infection and IFN treatment, and PLSCR1 has been reported to play an important role in IFN-dependent antiviral responses. Here, we demonstrate that HCMV plaque formation and major immediate early (MIE) gene expression are significantly increased in PLSCR1-KO human fibroblast cells. PLSCR1 reduces levels of the CREB•IE2 and CBP•IE2 complexes, which have been suggested to play important roles in HCMV replication through its interactions with CREB, CBP, and IE2. In addition, PLSCR1 expression represses transcription from the HCMV MIE promoter. Our results indicate that PLSCR1 plays important roles in the suppression of HCMV replication in the IFN-mediated host defense system.
人源磷脂酶 scramblase 1(PLSCR1)在干扰素(IFN)治疗和病毒感染后强烈表达,并被认为在 IFN 依赖性抗病毒反应中发挥重要作用。在这项研究中,我们发现高基础表达 PLSCR1 的 OUMS-36T-3(36T-3)细胞中的人巨细胞病毒(HCMV)斑块形成水平明显低于低基础表达 PLSCR1 的人胚肺(HEL)细胞。此外,PLSCR1 敲除(KO)36T-3 细胞中的 HCMV 斑块形成和复制水平明显高于亲本 36T-3 细胞,与 HEL 细胞相当。此外,与 PLSCR1-KO 细胞相比,在 HCMV 感染后,亲本 36T-3 细胞中 HCMV 主要早期(MIE)蛋白的表达受到抑制和/或延迟。我们还表明,PLSCR1 表达降低了 cAMP 反应元件(CRE)结合蛋白(CREB)•HCMV 早期蛋白 2(IE2)和 CREB 结合蛋白(CBP)•IE2 复合物的水平,这些复合物已被证明通过与 CREB、CBP 和 IE2 的相互作用在 IE2 介导的病毒早期启动子的转录激活中发挥重要作用。有趣的是,PLSCR1 表达抑制了 CRE 和 HCMV MIE 启动子调节的报告基因活性。这些观察结果首次揭示,PLSCR1 通过抑制病毒 MIE 和早期启动子的转录来负调控 HCMV 复制,并且 PLSCR1 表达可能有助于 IFN 介导的 HCMV 感染抑制。由于已经报道了几种 IFN 刺激基因(ISGs)抑制 HCMV 复制,因此认为 HCMV 复制受到 IFN 介导的宿主防御机制的调节,但机制尚不清楚。PLSCR1 的表达响应病毒感染和 IFN 处理而诱导,并且已经报道 PLSCR1 在 IFN 依赖性抗病毒反应中发挥重要作用。在这里,我们证明 PLSCR1-KO 人成纤维细胞中的 HCMV 斑块形成和主要早期(MIE)基因表达显着增加。PLSCR1 降低了 CREB•IE2 和 CBP•IE2 复合物的水平,这些复合物已被证明通过与 CREB、CBP 和 IE2 的相互作用在 HCMV 复制中发挥重要作用。此外,PLSCR1 表达抑制 HCMV MIE 启动子的转录。我们的结果表明,PLSCR1 在 IFN 介导的宿主防御系统中抑制 HCMV 复制中发挥重要作用。